PER 1.41% 7.0¢ percheron therapeutics limited

Clean insights and information easily found, page-60

  1. 13,147 Posts.
    lightbulb Created with Sketch. 1380
    So let’s have a look at the earnings of Sarepta
    We see they have 4 drugs in Dmd( all show no efficacy)
    Sarepta only have about 16% of the Dmd market
    Now
    PER could capture 100% of the Dmd market as stated .by Per

    Also stated possible $1 billion in revenue.(PER)
    Look at the MC of Sarepta

    This is why PER is Lazer focused with DMD…
    The strategy will be. Company maker



    https://hotcopper.com.au/data/attachments/6235/6235677-7f7937b21f65c244bcd95ac48449c72a.jpg
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.